Rohto Pharmaceutical Co.,Ltd. (TYO:4527)

Rohto Pharmaceutical Revenue

In the fiscal year ending March 31, 2025, Rohto Pharmaceutical had annual revenue of 308.63B JPY with 13.95% growth. Rohto Pharmaceutical had revenue of 82.73B in the quarter ending March 31, 2025, with 18.73% growth.

• Revenue: 308.63B
• Revenue Growth: +13.95%
• P/S Ratio: 1.50
• Revenue / Employee: 42.52M
• Employees: 7,259
• Market Cap: 461.42B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	308.63B	37.79B	13.95%
Mar 31, 2024	270.84B	32.18B	13.48%
Mar 31, 2023	238.66B	39.02B	19.54%
Mar 31, 2022	199.65B	18.36B	10.13%
Mar 31, 2021	181.29B	-7.04B	-3.74%